FISPB
IONS icon

Fideuram - Intesa Sanpaolo Private Banking’s Ionis Pharmaceuticals IONS Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.27M Sell
53,795
-474
-0.9% -$35.7K 0.13% 167
2026
Q1 		$4.08M Sell
54,269
-67,359
-55% -$5.32M 0.14% 149
2025
Q4 		$9.62M Buy
+121,628
New +$9.16M 0.35% 73

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's IONS Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking reduced its Ionis Pharmaceuticals (IONS) stake by 0.87% in Q2 2026, selling an estimated $35.7K and leaving 53,795 shares worth $4.27M. The position accounts for 0.13% of the portfolio, ranked #167.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in IONS in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.62M in Q4 2025. 513 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 53,795 shares of Ionis Pharmaceuticals worth $4.27M as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking sold 474 Ionis Pharmaceuticals shares in Q2 2026, an estimated $35.7K.
  • Ionis Pharmaceuticals made up 0.13% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #167 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Fideuram - Intesa Sanpaolo Private Banking's Ionis Pharmaceuticals position peaked at $9.62M in Q4 2025.
  • 513 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.